Total Funding
75
63
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
54017
Nectin Therapeutics is a startup company dedicated to the development of next generation immuno-oncology antibodies.
- Keren Paz: Chief Development Officer
- Fabian Tenenbaum: Chief Executive OfficerPast Role: ANTERIOS, Chief Business Officer & Chief Financial Officer
About the Company
Nectin Therapeutics is developing novel monoclonal antibodies directed towards members of the Nectin family of receptors and ligands that have major roles in the immune checkpoint mechanisms relevant for cancer immune therapy. These novel antibodies are developed for the treatment of solid and hematological malignancies.
